Почетна › Рак дојке › Округ Колумбија › Washington
Kliničke studije za Рак дојке u gradu Washington, DC
44 studija za Рак дојке traži učesnike na lokacijama u gradu Washington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Тражи се учесникОпсервациона студија
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Тражи се учесникФаза 2
- MedStar Washington Hosp Center, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Тражи се учесникФаза 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · 6 ми удаљено
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Тражи се учесникФаза 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Тражи се учесникФаза 3
- MedStar Washington Hospital Center, Washington D.C.
Genomic Services Research Program
Тражи се учесникОпсервациона студија
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Тражи се учесникФаза 2
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Collection of Blood From Patients With Cancer
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Тражи се учесникФаза 2
- The George Washington Medical facility Associates, Washington D.C.
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Walter Reed National Military Medical Center, Bethesda · 7 ми удаљено
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Georgetown University Medical Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Тражи се учесникФаза 1/2
- Georgetown University, Washington D.C.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Тражи се учесникФаза 3
- Georgetown University Medical Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Тражи се учесникФаза 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 ми удаљено
E-Mindfulness Approaches for Living After Breast Cancer
Тражи се учесникФаза 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- и још 2
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 ми удаљено
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- и још 5
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Тражи се учесникФаза 2
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Тражи се учесникФаза 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Cancer Support Community Research & Training Institute, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Тражи се учесникОпсервациона студија
- Holy Cross Hospital - Silver Spring, Silver Spring · 7 ми удаљено
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · 7 ми удаљено
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Тражи се учесникФаза 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · 7 ми удаљено
- Maryland Oncology Hematology P.A., Bethesda · 7 ми удаљено
- и још 1
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Тражи се учесникОпсервациона студија
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Тражи се учесник
- Walter Reed National Military Medical Center, Bethesda · 7 ми удаљено
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Тражи се учесникФаза 3
- Holy Cross Hospital ( Site 0073), Silver Spring · 7 ми удаљено
Older Breast Cancer Patients: Risk for Cognitive Decline
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Georgetown University, Washington D.C.
Identifying Patterns in the Breath of Individuals With Breast Cancer
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- GW Comprehensive Breast Center, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 ми удаљено
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Тражи се учесникФаза 2
- Georgetown University Medical Center, Washington D.C.
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Тражи се учесник
- Sibley Memorial Hospital, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Тражи се учесник
- National Institutes of Health Clinical Center, Bethesda · 7 ми удаљено
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Тражи се учесникФаза 3
- Sibley Memorial Hospital, Washington D.C.
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Тражи се учесникФаза 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Тражи се учесникФаза 2
- National Institute of Health Clinical Center, Bethesda · 7 ми удаљено
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- Georgetown University Medical Center, Washington D.C.
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Тражи се учесникФаза 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- и још 2
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Тражи се учесникФаза 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Тражи се учесник
- Sibley Memorial Hospital, Washington D.C.
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Тражи се учесникОпсервациона студија
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Silver Spring · 7 ми удаљено
- Massive Bio SYNERGY-AI site, Bethesda · 7 ми удаљено
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Тражи се учесник
- Georgetown University, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Тражи се учесникОпсервациона студија
- Maryland Oncology Hematology, PA, Silver Spring · 7 ми удаљено
- Maryland Oncology Hematology - Bethesda, Bethesda · 7 ми удаљено
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Тражи се учесникОпсервациона студија
- George Washington University, Washington D.C.
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Washington
- Рак (све врсте)60 студија
- Немалоклетни карцином плућа55 студија
- Метастатски карцином44 студија
- Рак плућа41 студија
- Рак простате39 студија
- Гојазност34 студија
- Колоректални карцином28 студија
- Кардиоваскуларне болести27 студија
- Рак бешике26 студија
- Рак јајника25 студија
- Лимфом23 студија
- Hronična limfocitna leukemija22 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.